Acceleration of the alcohol oxidation rate in rats with aloin, a quinone derivative of Aloe

Biochemical Pharmacology

Volumn 52, Issue 9, 1996, Pages 1461-1468

  Chung, Jin Ho ^a   Cheong, Jeong Cheol ^a   Lee, Joo Young ^a   Roh, Hyung Keun ^b   Cha, Young Nam ^b  

^a Seoul National University   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

Aloe; aloe emodin; aloin; ethanol metabolism; quinone; quinone reductase

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALOE EMODIN; ALOIN; ANTHRAQUINONE DERIVATIVE; ASPARTATE AMINOTRANSFERASE; GLYCOSIDE; QUINONE DERIVATIVE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ALCOHOL OXIDATION; ALOE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG ELIMINATION; DRUG METABOLISM; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER LEVEL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ALANINE TRANSAMINASE; ALCOHOLIC INTOXICATION; ALOE; ANIMALS; ASPARTATE AMINOTRANSFERASES; EMODIN; ETHANOL; FEMALE; KINETICS; LIVER; METABOLIC CLEARANCE RATE; OXIDATION-REDUCTION; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 0030575939     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00514-X     Document Type: Article

References (43)

1. 1. Sakai K, Sattoh Y, Ikawa C and Nishhata T, Effect of water extracts of Aloe and some herbs in decreasing blood ethanol concentration in rats. Chem Pharm Bull (Tokyo) 37: 155-159, 1989.
2. 2. Grindlay D and Reynolds T, The Aloe vera phenomenon: A review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol 16: 117-151, 1986.
3. 3. John SH, A drug for all seasons: Medical and pharmacological history of Aloe. Bull NY Acad Med 66: 647-659, 1990.
4. 4. Hirata T and Suga T, Biologically active constituents of leaves and roots of Aloe arborescens var. natalensis. Z Naturforch 32c: 731-734, 1977.
5. 5. McCauley RL, Heggers JP and Robson MC, Frostbite. Methods to minimize tissue loss. Postgrad Med 88: 67-77, 1990.
6. 6. Davis RH, Rosenthan KY, Cesario LR and Rauw GA, Processed Aloe vera administered topically inhibits inflammation. J Am Podiatr Med Assoc 79: 395-397, 1989.
7. 7. Saito H, Ishiguro T, Imanishi K and Suzuki I, Pharmacological studies on a plant lectin aloctin A. II. Inhibitory effect of aloctin A on experimental models of inflammation in rats. Jpn J Pharmacol 32: 139-142, 1982.
8. 8. Lushbaugh CC and Hale DB, Experimental acute radiodermatitis following beta irradiation. V, Histopathological study of the mode of action of therapy with Aloe vera. Cancer 6: 690-698, 1953.
9. 9. Davis RH, Parker WL, Samson RT and Murdoch DP, Isolation of stimulatory system in Aloe extract. J Am Podiatr Med Assoc 81: 473-478, 1991.
10. 10. Rodriguez-Bigas M, Cruz NI and Suarez A, Comparative evaluation of Aloe vera in the management of burn wounds in guinea pigs. Plast Reconstr Surg 81: 386-389, 1988.
11. 11. Ajabnoor MA, Effects of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol 28: 215-220, 1990.
12. 12. Sydiskis RJ, Owen DG, Lohr JL, Rosler KA and Blomster RN, Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother 35: 2463-2466, 1991.
13. 13. Hart LA, van den Berg AJ, Kuis L, van Dijk H and Labadie RP, An anti-complementary polysaccharide with immunological adjuvant activity from the leaf of parenchyma gel of Aloe vera. Planta Med 55: 509-512, 1989.
14. 14. Hart LA, Nibbering PH, van den Barselaar MT, van Dijk H, van den Berg AJJ and Labadie RP, Effects of low molecular constituents from Aloe vera gel on oxidative metabolism and cytotoxic and bactericidal activities of human neutrophils. Int J Immunopharmacol 12: 427-434, 1990.
15. 15. Womble D and Helderman JH, Enhancement of alloresponsiveness of human lymphocytes by acemannan (Carrisyn™). Int J Immunopharmacol 10: 967-974, 1988.
16. 16. Shida T, Yagi A, Nishimura H and Nishioka I, Effect of Aloe extract on peripheral phagocytosis in adult bronchial asthma. Planta Med 51: 273-275, 1985.
17. 17. Wyk BE, Oudtshoorn MCB and Smith GF, Geographical variation in the major compounds of Aloe ferox leaf exudate. Planta Med 61: 250-253, 1995.
18. 18. Franz G and Grun M, Chemistry, occurrence and biosynthesis of C-glycosyl compounds in plants. Planta Med 47: 131-140, 1983.
19. 19. Hattori M, Kanda T, Shu YZ, Akao T, Kobashi K and Namba T, Metabolism of barbaloin by intestinal bacteria. Chem Pharm Bull (Tokyo) 36: 4462-4466, 1988.
20. 20. Che QM, Akao T, Hattori M, Kobashi K and Namba T, Isolation of human intestinal bacterium capable of transforming barbaloin to aloe-emodin anthrone. Planta Med 57: 15-19, 1991.
21. 21. Theorell HS and Bonnichsen R, Studies on liver alcohol dehydrogenase. I. Equilibria and initial reaction velocities. Acta Chem Scand 5: 1105-1126, 1951.
22. 22. Theorell HS and Chance B, Studies on liver alcohol dehydrogenase. II. The kinetics of the compound of horse liver alcohol dehydrogenase and reduced diphosphopyridine nucleotide. Acta Chem Scand 5: 1127-1144, 1951.
23. 23. Lieber CS and Savolainen M, Ethanol and lipids. Alcohol Clin Exp Res 8: 409-423, 1984.
24. 24. Lind C, Hochstein P and Ernster L, DT-Diaphorase as a quinone reductase: A cellular device against semiquinone and superoxide radical formation. Arch Biochem Biophys 216: 178-185, 1982.
25. 25. Prochaska JJ and Talalay P, The role of NAD(P)H:quinone reductase in protection against the toxicity of quinones and related agents. In: Oxidative Stress: Oxidants and Antioxidants (Ed. Sies H), pp. 195-211. Academic Press, London, 1991.
26. 26. Chung JH, Rubin RJ and Cha YN, Effects of vitamin K, and menadione on ethanol metabolism and toxicity. Drug Chem Toxicol 164: 383-394, 1993.
27. 27. Chung JH, Cha YN and Rubin RJ, Role of quinone reductase in in vivo ethanol metabolism and toxicity. Toxicol Appl Pharmacol 124: 123-130, 1994.
28. 28. Groom QJ and Reynolds T, Barbaloin in Aloe species. Planta Med 53: 345-348, 1987.
29. 29. Bonnichsen RK and Theorell H, An enzymatic method for the micro-determination of ethanol. Scand J Clin Lab Invest 3: 58-62, 1951.
30. 30. Van Handel E and Zilversmit DB, Micromethod for direct determination of serum triglycerides. J Lab Clin Med 50: 152-157, 1957.
31. 31. Butler WM, Maling HM, Horning MG and Brodie BB, The direct determination of liver triglycerides. J Lipid Res 2: 95-96, 1961.
32. 32. Widmark EMP, Verteilung und unwandltung des athyl alkohols in organismus des hundes. Biochem Z 267: 128-134, 1933.
33. 33. Ryle PR, Chakraborty J and Thomson AD, The role of the hepatocellular redox state in the hepatic triglyceride accumulation following acute ethanol administration. Biochem Pharmacol 35: 3159-3164, 1986.
34. 34. Lieber CS, Alcohol and the liver: 1984 update. Hepatology 4: 1243-1260, 1984.
35. 35. Dawson AG, What governs ethanol metabolism? In: Metabolic Regulation (Ed. Ochs ES), pp. 87-91. Elsevier, New York, 1985.
36. 36. Higgins JJ, Control of ethanol oxidation and its interaction with other metabolic systems. In: Biochemistry and Pharmacology of Ethanol (Eds. Majchrowicz E and Noble EP), pp. 249-351. Plenum Press, New York, 1979.
37. 37. Berry MN, Fanning DC and Wallace PG, Ethanol oxidation in isolated hepatocytes. Adv Exp Med Biol 132: 403-411, 1979.
38. 38. Ryle PR, Chakraborty J and Thomson AD, The effect of methylene blue on the hepatocellular redox state and liver lipid content during chronic ethanol feeding in the rat. Biochem J 232: 877-882, 1985.
39. 39. Cha Y-N and Heine HS, Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-ditert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res 42: 2609-2615, 1982.
40. 40. De Long MJ, Prochaska HJ and Talalay P, Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: A model system for the study of anticarcinogens. Proc Natl Acad Sci USA 83: 787-791, 1986.
41. 41. Riley RJ and Workman P, DT-Diaphorase and cancer chemotherapy. Biochem Pharmacol 43: 1657-1669, 1992.
42. 42. Ishii Y, Tanizawa H, Ikemoto C and Takino Y, Studies of Aloe. I. Cathartic effects. Yakugaku Zasshi 101: 254-258, 1981.
43. 43. Day CP and Yeaman SJ, The biochemistry of alcohol-induced fatty liver. Biochim Biophys Acta 1215: 33-48, 1994.